Heng Zhang

Heng Zhang

Auto-generated profile, based on publicly available information

Heng Zhang

Department of Oncology, Institute of Integrative Oncology, Tianjin Union Medical Center, 190, Jieyuan Road, Hongqiao District, Tianjin, 300121, China

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 August 2017 in BMC Complementary and Alternative Medicine
Verified
Journal Article
Open access
PDF file
HZHeng Zhang
Heng Zhang
HYHao Yan
Hao Yan
XZXIAOLIANG ZHOU
XIAOLIANG ZHOU
HWHuaqing Wang
Huaqing Wang
YYYiling Yang
Yiling Yang
HWHui Wang
Hui Wang
Intestinal injury is a potential cause of death after high-dose radiation exposure. The aim of the present study was to investigate the protective effects of resveratrol against radiation-induced small intestine injury. C57BL/6 N mice were irradiated and treated with resveratrol and/or Ex527 (a potent Sirt1 inhibitor), and subsequent examining intestinal morphological changes, and crypt cell apoptosis. Then, the expression and enzyme activity of SOD2 in the small intestine were examined. Furthermore, Sirt1 and acetylated p53 expression was analysed. Compared to the vehicle control, treatment with resveratrol improved intestinal morphology, decreased apoptosis of crypt cells, maintained cell regeneration, and ameliorated SOD2 expression and activity. Resveratrol also regulated Sirt1 and acetylated p53 expression perturbed by irradiation in the small intestine. The protective effect of resveratrol against ionizing radiation induced small intestine injury was significantly inhibited by Ex527. Our results suggest that resveratrol decreases the effects of radiation on intestinal injury at least partly via activation of Sirt1.

24 June 2014 in BioMed Research International
Verified
Journal Article
Open access
PDF file
HWHui Wang
Hui Wang
YYYi-Ling Yang
Yi-Ling Yang
HZHeng Zhang
Heng Zhang
HYHao Yan
Hao Yan
XWXiao-Jing Wu
Xiao-Jing Wu
CZChun-Ze Zhang
Chun-Ze Zhang
Ionizing radiation (IR) is known not only to cause acute bone marrow (BM) suppression but also to lead to long-term residual hematopoietic injury. These effects have been attributed to IR inducing the generation of reactive oxygen species (ROS) in hematopoietic cells. In this study, we examined if isorhapontigenin and heyneanol-A, two analogues of resveratrol, could mitigate IR-induced BM suppression. The results of cell viability assays, clonogenic assays, and competitive repopulation assays revealed that treatment with these compounds could protect mice BM mononuclear cells (BMMNC), hematopoietic progenitor cells, and hematopoietic stem cells from IR-induced BM suppression. Moreover, the expression of genes related to the endogenous cellular antioxidant system in hematopoietic cells was analyzed. The expression and activity of SOD2 and GPX1 were found to be decreased in irradiated BMMNC, and the application of the resveratrol analogues could ameliorate this damage. Our results suggest that in comparison with resveratrol and isorhapontigenin, treatment with heyneanol-A can protect hematopoietic cells from IR-induced damage to a greater degree; the protective effects of these compounds are probably the result of their antioxidant properties.